125 related articles for article (PubMed ID: 26195837)
1. Cerebral vasospasm after selective amygdalohippocampectomy.
Chakravarty A; Anand S
Indian J Anaesth; 2015 Jun; 59(6):380-2. PubMed ID: 26195837
[No Abstract] [Full Text] [Related]
2. Rate of vasospasm following the transsylvian versus transcortical approach for selective amygdalohippocampectomy.
Schaller C; Jung A; Clusmann H; Schramm J; Meyer B
Neurol Res; 2004 Sep; 26(6):666-70. PubMed ID: 15327757
[TBL] [Abstract][Full Text] [Related]
3. Diffuse vasospasm after transcortical temporal lobectomy for intractable epilepsy.
Dickerson JC; Hidalgo JA; Smalley ZS; Shiflett JM
Acta Neurochir (Wien); 2018 Sep; 160(9):1883-1887. PubMed ID: 29987392
[TBL] [Abstract][Full Text] [Related]
4. Selective amygdalohippocampectomy via trans-superior temporal gyrus keyhole approach.
Mathon B; Clemenceau S
Acta Neurochir (Wien); 2016 Apr; 158(4):785-789. PubMed ID: 26852036
[TBL] [Abstract][Full Text] [Related]
5. How I do it - selective amygdalohippocampectomy via a navigated temporobasal approach, when veins forbid elevation of the temporal lobe.
Delev D; Schramm J; Clusmann H
Acta Neurochir (Wien); 2018 Mar; 160(3):597-601. PubMed ID: 29147777
[TBL] [Abstract][Full Text] [Related]
6. Advanced surgical approach for selective amygdalohippocampectomy through neuronavigation.
Wurm G; Wies W; Schnizer M; Trenkler J; Holl K
Neurosurgery; 2000 Jun; 46(6):1377-82; discussion 1382-3. PubMed ID: 10834642
[TBL] [Abstract][Full Text] [Related]
7. Selective amygdalohippocampectomy: which route is the best? An experimental study in 80 human cerebral hemispheres.
Gonçalves-Ferreira A; Miguéns J; Farias JP; Melancia JL; Andrade M
Stereotact Funct Neurosurg; 1994; 63(1-4):182-91. PubMed ID: 7624633
[TBL] [Abstract][Full Text] [Related]
8. Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice.
Kawakita F; Fujimoto M; Liu L; Nakano F; Nakatsuka Y; Suzuki H
Mol Neurobiol; 2017 Oct; 54(8):6624-6633. PubMed ID: 27738873
[TBL] [Abstract][Full Text] [Related]
9. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
Zhang Z; Nagata I; Kikuchi H; Xue JH; Sakai N; Sakai H; Yanamoto H
Stroke; 2001 Jul; 32(7):1665-72. PubMed ID: 11441217
[TBL] [Abstract][Full Text] [Related]
10. Selective posterior cerebral artery amobarbital test: a predictor of memory following subtemporal selective amygdalohippocampectomy.
Catapano JS; Whiting AC; Wang DJ; Hlubek RJ; Labib MA; Morgan CD; Brigeman S; Fredrickson VL; Cavalcanti DD; Smith KA; Ducruet AF; Albuquerque FC
J Neurointerv Surg; 2020 Feb; 12(2):165-169. PubMed ID: 31320550
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction pathways in cerebral vasospasm.
Zubkov AY; Nanda A; Zhang JH
Pathophysiology; 2003 Jan; 9(2):47-61. PubMed ID: 14567936
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial nicardipine for the treatment of cerebral vasospasm in postpartum cerebral angiopathy: a case study and review of literature.
Lele A; Lyon T; Pollack A; Husmann K; Reeves A
Int J Neurosci; 2011 Oct; 121(10):537-42. PubMed ID: 21812738
[TBL] [Abstract][Full Text] [Related]
13. Cognitive changes after unilateral cortico-amygdalohippocampectomy unilateral selective-amygdalohippocampectomy mesial temporal lobe epilepsy.
Tanriverdi T; Olivier A
Turk Neurosurg; 2007 Apr; 17(2):91-9. PubMed ID: 17935023
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of temporal pole resection with amygdalohippocampectomy versus selective amygdalohippocampectomy on material-specific memory in patients with mesial temporal lobe epilepsy.
Helmstaedter C; Richter S; Röske S; Oltmanns F; Schramm J; Lehmann TN
Epilepsia; 2008 Jan; 49(1):88-97. PubMed ID: 17941848
[TBL] [Abstract][Full Text] [Related]
15. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.
Senbokuya N; Kinouchi H; Kanemaru K; Ohashi Y; Fukamachi A; Yagi S; Shimizu T; Furuya K; Uchida M; Takeuchi N; Nakano S; Koizumi H; Kobayashi C; Fukasawa I; Takahashi T; Kuroda K; Nishiyama Y; Yoshioka H; Horikoshi T
J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic evaluation with dynamic DSA during the treatment of cerebral vasospasm: a retrospective study.
Touho H
Surg Neurol; 1995 Jul; 44(1):63-73; discussion 73-4. PubMed ID: 7482257
[TBL] [Abstract][Full Text] [Related]
17. How I do it - selective amygdalohippocampectomy via subtemporal approach.
Sajko T; Skoro I; Rotim K
Acta Neurochir (Wien); 2013 Dec; 155(12):2381-7. PubMed ID: 23989995
[TBL] [Abstract][Full Text] [Related]
18. Cerebral blood flow reactivity in patients undergoing selective amygdalohippocampectomy for epilepsy of mesial temporal origin. A prospective randomized comparison of the trans-Sylvian and the transcortical approach.
Schatlo B; Jägersberg M; Paass G; Faltermeier R; Streich J; Meyer B; Schaller K
Neurol Res; 2015; 37(12):1037-46. PubMed ID: 26923574
[TBL] [Abstract][Full Text] [Related]
19. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
[TBL] [Abstract][Full Text] [Related]
20. Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates.
Clatterbuck RE; Gailloud P; Ogata L; Gebremariam A; Dietsch GN; Murphy KJ; Tamargo RJ
J Neurosurg; 2003 Aug; 99(2):376-82. PubMed ID: 12924713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
